Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone production
Carregando...
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2019
Editora
BIOSCIENTIFICA LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
HUANG, Yuefei
TING, Pei Yee
YAO, Tham M.
HOMMA, Tsuyoshi
BROOKS, Danielle
ADLER, Gail K.
ROMERO, Jose R.
WILLIAMS, Jonathan S.
POJOGA, Luminita H.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JOURNAL OF ENDOCRINOLOGY, v.240, n.2, p.111-122, 2019
Resumo
Human risk allele carriers of lysine-specific demethylase 1 (LSD1) and LSD1-deficient mice have salt-sensitive hypertension for unclear reasons. We hypothesized that LSD1 deficiency causes dysregulation of aldosterone's response to salt intake resulting in increased cardiovascular risk factors (blood pressure and microalbumin). Furthermore, we determined the effect of biological sex on these potential abnormalities. To test our hypotheses, LSD1 male and female heterozygote-knockout (LSD1+/-) and WT mice were assigned to two age groups: 18 weeks and 36 weeks. Plasma aldosterone levels and aldosterone production from zona glomerulosa cells studied ex vivo were greater in both male and female LSD1+/- mice consuming a liberal salt diet as compared to WT mice consuming the same diet. However, salt-sensitive blood pressure elevation and increased microalbuminuria were only observed in male LSD1+/- mice. These data suggest that LSD1 interacts with aldosterone's secretory response to salt intake. Lack of LSD1 causes inappropriate aldosterone production on a liberal salt diet; males appear to be more sensitive to this aldosterone increase as males, but not females, develop salt sensitivity of blood pressure and increased microalbuminuria. The mechanism responsible for the cardiovascular protective effect in females is uncertain but may be related to estrogen modulating the effect of mineralocorticoid receptor activation.
Palavras-chave
lysine-specific demethylase 1, sex, blood pressure, aldosterone
Referências
- Abbate M, 1999, NEPHROL DIAL TRANSPL, V14, P304, DOI 10.1093/ndt/14.2.304
- Baldoncini R, 1999, KIDNEY INT, V56, P1499, DOI 10.1046/j.1523-1755.1999.00672.x
- Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1053/cmaj.061590
- Baudrand R, 2017, HYPERTENSION, V69, P950, DOI 10.1161/HYPERTENSIONAHA.116.08952
- Baudrand R, 2015, CIRCULATION, V132, P1825, DOI 10.1161/CIRCULATIONAHA.115.016759
- Baudrand R, 2014, CURR OPIN NEPHROL HY, V23, P32, DOI 10.1097/01.mnh.0000436543.48391.e0
- Bennesch MA, 2016, NUCLEIC ACIDS RES, V44, P8655, DOI 10.1093/nar/gkw522
- Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007
- BRALEY LM, 1981, ENDOCRINOLOGY, V109, P960, DOI 10.1210/endo-109-3-960
- Braley LM, 1996, ENDOCRINOLOGY, V137, P4773, DOI 10.1210/en.137.11.4773
- Brown JM, 2017, ANN INTERN MED, V167, P630, DOI 10.7326/M17-0882
- Bubb KJ, 2012, BRIT J PHARMACOL, V167, P298, DOI 10.1111/j.1476-5381.2012.02036.x
- CARVALHO JJM, 1989, HYPERTENSION, V14, P238, DOI 10.1161/01.HYP.14.3.238
- Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446
- Chong C, 2017, J ENDOCRINOL, V232, P525, DOI 10.1530/JOE-16-0452
- Chuengsamarn S, 2013, METABOLISM, V62, P275, DOI 10.1016/j.metabol.2012.07.013
- Coylewright M, 2008, HYPERTENSION, V51, P952, DOI 10.1161/HYPERTENSIONAHA.107.105742
- Danser AHJ, 1998, J HYPERTENS, V16, P853
- Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101
- Epstein M, 2001, INTERNAL MED, V40, P573, DOI 10.2169/internalmedicine.40.573
- FELICIO LS, 1984, BIOL REPROD, V31, P446, DOI 10.1095/biolreprod31.3.446
- Franco V, 2006, J AM COLL NUTR, V25, p247S, DOI 10.1080/07315724.2006.10719574
- Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104
- Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038
- Garza AE, 2015, HYPERTENSION, V65, P211, DOI 10.1161/HYPERTENSIONAHA.114.04233
- Gomez-Sanchez EP, 2010, EXP PHYSIOL, V95, P120, DOI 10.1113/expphysiol.2009.048900
- GOULD MM, 1993, BMJ-BRIT MED J, V306, P240, DOI 10.1136/bmj.306.6872.240
- Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884
- HIMMELMANN A, 1994, J HUM HYPERTENS, V8, P485
- Hollenberg NK, 2004, KIDNEY INT, V66, P1, DOI 10.1111/j.1523-1755.2004.00701.x
- Hostetter TH, 2003, J AM SOC NEPHROL, V14, P2395, DOI 10.1097/01.ASN.0000086472.65806.73
- Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092
- Hundemer GL, 2018, LANCET DIABETES ENDO, V6, P51, DOI 10.1016/S2213-8587(17)30367-4
- Kang AK, 2002, CURR HYPERTENS REP, V4, P143, DOI 10.1007/s11906-002-0039-9
- Karatas A, 2008, HYPERTENSION, V51, P1177, DOI 10.1161/HYPERTENSIONAHA.107.107938
- Kathiresan S, 2005, AM J HYPERTENS, V18, P657, DOI 10.1016/j.amjhyper.2004.12.005
- KATZ F H, 1972, Steroids and Lipids Research, V3, P90
- Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006
- Krug AW, 2013, AGE, V35, P1809, DOI 10.1007/s11357-012-9480-0
- Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb
- Lumbers ER, 1999, REGUL PEPTIDES, V80, P91, DOI 10.1016/S0167-0115(99)00026-9
- Manrique C, 2013, ENDOCRINOLOGY, V154, P3632, DOI 10.1210/en.2013-1256
- Masineni SN, 2005, AM J HYPERTENS, V18, P878, DOI 10.1016/j.amjhyper.2004.12.014
- Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020
- Miller JA, 1999, KIDNEY INT, V55, P278, DOI 10.1046/j.1523-1755.1999.00260.x
- Mueller KB, 2014, ENDOCRINOLOGY, V155, P4461, DOI 10.1210/en.2014-1270
- NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327
- Nitta K, 2004, AM J MED, V117, P444, DOI 10.1016/j.amjmed.2004.04.020
- Oestreicher EM, 2006, KIDNEY INT, V70, P1759, DOI 10.1038/sj.ki.5001897
- Ostchega Y, 2008, NCHS DATA BRIEF, P1
- OUCHI Y, 1987, HYPERTENSION, V9, P172, DOI 10.1161/01.HYP.9.2.172
- Pimenta E, 2008, HYPERTENSION, V51, P339, DOI 10.1161/HYPERTENSIONAHA.107.100701
- Pojoga LH, 2015, J PHARMACOL EXP THER, V355, P32, DOI 10.1124/jpet.115.226043
- Pojoga LH, 2014, J PHARMACOL EXP THER, V348, P260, DOI 10.1124/jpet.113.209189
- Pojoga LH, 2011, AM J PHYSIOL-HEART C, V301, pH1862, DOI 10.1152/ajpheart.00513.2011
- Pojoga LH, 2010, ENDOCRINOLOGY, V151, P1236, DOI 10.1210/en.2009-0514
- Rayner B, 2006, SAUDI J KIDNEY DIS T, V17, P469
- Reckelhoff JF, 2010, STEROIDS, V75, P745, DOI 10.1016/j.steroids.2010.05.020
- Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199
- Ricchiuti V, 2011, J ENDOCRINOL, V211, P47, DOI 10.1530/JOE-10-0458
- Rodriguez-Iturbe B, 2007, NEPHROL DIAL TRANSPL, V22, P992, DOI 10.1093/ndt/gfl757
- Sandberg K, 2003, ADV RENAL REPLACE TH, V10, P15, DOI 10.1053/jarr.2003.50006
- Sato A, 2003, HYPERTENSION, V41, P64, DOI 10.1161/01.HYP.0000044937.95080.E9
- Schrader J, 2006, J HYPERTENS, V24, P541, DOI 10.1097/01.hjh.0000209991.48928.c4
- Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39
- Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012
- Shukri MZ, 2018, HYPERTENSION, V71, P1083, DOI 10.1161/HYPERTENSIONAHA.117.11087
- Simon PHG, 2016, AM J HYPERTENS, V29, P891, DOI 10.1093/ajh/hpw021
- Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003
- Spyroglou A, 2012, J ENDOCRINOL, V215, P375, DOI 10.1530/JOE-12-0429
- Stier CT, 2003, AM J PHYSIOL-ENDOC M, V285, pE232, DOI 10.1152/ajpendo.00029.2003
- Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268
- Watson Linley E, 2013, Front Biosci (Elite Ed), V5, P922
- Williams G, 2005, HEART FAIL REV, V10, P7, DOI 10.1007/s10741-005-2343-3
- WILLIAMS GH, 1991, HYPERTENSION, V18, pS143
- Williams JS, 2012, AM J HYPERTENS, V25, P812, DOI 10.1038/ajh.2012.43
- YONG LC, 1993, AM J EPIDEMIOL, V138, P973, DOI 10.1093/oxfordjournals.aje.a116817